Who
Raymond Anderson
Director
Company insider
Files Form 4 as: Director, Monopar Therapeutics; Director, Raptor Pharmaceutical; Director, Raptor Pharmaceuticals.
In numbers
- Trades disclosed
- 150
- Buys
- 0
- Sells
- 20
- Bought
- $0
- Sold
- $3.3M
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 26 May 2006
- Last trade
- 25 Aug 2026
- Last filed
- 28 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Aug 2026filed 28 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Code M | $42K1,402 at $30.00 | filing |
| 25 Aug 2026filed 28 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Code M | $52K1,740 at $30.00 | filing |
| 25 Aug 2026filed 28 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Sold | $76K694 at $110.04 | filing |
| 25 Aug 2026filed 28 Aug 2026 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,402 at $0.00 | filing |
| 25 Aug 2026filed 28 Aug 2026 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,740 at $0.00 | filing |
| 25 Aug 2026filed 28 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Sold | $72K646 at $111.07 | filing |
| 25 Aug 2026filed 28 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Sold | $204K1,802 at $113.05 | filing |
| 25 Aug 2026filed 28 Aug 2026 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,402 at $0.00 | filing |
| 25 Aug 2026filed 28 Aug 2026 | MNPR Monopar Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,740 at $0.00 | filing |
| 25 Aug 2026filed 28 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Code M | $42K1,402 at $30.00 | filing |
| 25 Aug 2026filed 28 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Code M | $52K1,740 at $30.00 | filing |
| 25 Aug 2026filed 28 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Sold | $76K694 at $110.04 | filing |
| 25 Aug 2026filed 28 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Sold | $72K646 at $111.07 | filing |
| 25 Aug 2026filed 28 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Sold | $204K1,802 at $113.05 | filing |
| 25 Aug 2026filed 27 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Sold | $76K694 at $110.04 | filing |
| 25 Aug 2026filed 27 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Sold | $71K646 at $110.07 | filing |
| 25 Aug 2026filed 27 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Sold | $204K1,802 at $113.05 | filing |
| 25 Aug 2026filed 27 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Sold | $76K694 at $110.04 | filing |
| 25 Aug 2026filed 27 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Sold | $71K646 at $110.07 | filing |
| 25 Aug 2026filed 27 Aug 2026 | MNPR Monopar TherapeuticsBiotechnology | SEC FORM 4 Sold | $204K1,802 at $113.05 | filing |
News
No headline names them, or the companies they trade most, lately.